The devastating impact of the opioid crisis has led to an increase in opiate class action lawsuits, shedding light on the pharmaceutical industry’s practices. The opioid epidemic has resulted in the loss of over 400,000 lives in the past two decades and has imposed trillions of dollars in societal costs. Recent evidence has exposed the strategies of influence employed by opioid companies, revealing their relationships with various individuals and institutions. As the public becomes more informed about these practices, it is crucial to understand the implications and potential changes in pharmaceutical practices.
How to Choose from the Top 10 CBSE Boarding Schools in India
A quality boarding school creates an environment where learning extends far beyond textbooks. Students benefit from structured routines, experienced mentors, and opportunities to participate…